Lexagene Holdings (Lexagene Holdings) EV-to-EBIT : -1.51 (As of Jun. 04, 2024)

Lexagene Holdings EV-to-EBIT Chart

Lexagene Holdings Annual Data
	Trend	Mar13	Mar14	Mar15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
EV-to-EBIT		Get a 7-Day Free Trial					-14.27	-3.92	-8.12	-9.84	-2.61

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-EBIT	Get a 7-Day Free Trial															-4.23	-2.61	-2.04	-2.20	-2.91

Competitive Comparison of Lexagene Holdings's EV-to-EBIT

For the Medical Devices subindustry, Lexagene Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's EV-to-EBIT falls into.

Lexagene Holdings EV-to-EBIT Calculation

Lexagene Holdings's EV-to-EBIT for today is calculated as:

Lexagene Holdings's current Enterprise Value is $12.23 Mil.
Lexagene Holdings's EBIT for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings  (OTCPK:LXXGQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lexagene Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2022 is calculated as:

Lexagene Holdings's Enterprise Value for the quarter that ended in Nov. 2022 was $24.63 Mil.
Lexagene Holdings's EBIT for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description